Lv2
130 积分 2025-10-08 加入
Deep Analysis of Desmoglein-3–Reactive CD4+ T Cells in Pemphigus Vulgaris Reveals a Type 17/Type 2 T-Cell Signature
9天前
已完结
Autoreactive IgG and IgA B Cells Evolve through Distinct Subclass Switch Pathways in the Autoimmune Disease Pemphigus Vulgaris
24天前
已关闭
Beyond the skin: B cells in pemphigus vulgaris, tolerance and treatment. British Journal of Dermatology
26天前
已关闭
Gut microbiota and skin pathologies: Mechanism of the gut-skin axis in atopic dermatitis and psoriasis
29天前
已完结
Successful Treatment of Refractory Severe Pemphigus With Telitacicept as Adjunctive Therapy: Two Case Reports
1个月前
已完结
Characterization and treatment outcomes of rituximab therapy in super-responders and rituximab-refractory pemphigus patients: A single-center retrospective study
1个月前
已完结
Rituximab as Single Long-term Maintenance Therapy in Patients With Difficult-to-Treat Pemphigus
2个月前
已完结
Exploring telitacicept in a patient with pemphigus vulgaris
3个月前
已完结
Clinical relevance of circulating autoantigen‑specific T‑follicular helper and regulatory T cells in pemphigus vulgaris
5个月前
已关闭
Immune interplay from circulation to local lesion in pemphigus
5个月前
已完结
皖公网安备34019202002308
